[Humoral immune deficiency in paraproteinemias].
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000368:Aged; D000917:Antibody Formation; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001424:Bacterial Infections / Q000209:etiology* / Q000276:immunology; D005260:Female; D006801:Humans; D007070:Immunoglobulin A / Q000032:analysis; D007136:Immunoglobulins / Q000032:analysis; D007153:Immunologic Deficiency Syndromes / Q000150:complications* / Q000382:microbiology; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007519:Isoantigens; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000150:complications* / Q000188:drug therapy / Q000382:microbiology; D012698:Serologic Tests; D013743:Tetanus Antitoxin / Q000627:therapeutic use; D008258:Waldenstrom Macroglobulinemia / Q000150:complications* / Q000188:drug therapy / Q000382:microbiology
D000305:Adrenal Cortex Hormones; D000970:Antineoplastic Agents; D007070:Immunoglobulin A; D007136:Immunoglobulins; D007166:Immunosuppressive Agents; D007519:Isoantigens; D013743:Tetanus Antitoxin
Humorale Infektabwehrschwäche bei paraproteinämischen Erkrankungen.